Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

HILS Hillstream BioPharma

Watchlist
1.370
+0.130+10.48%
Close  02/08 16:00 ET
1.330
-0.040-2.92%
Pre Mkt Price 02/09 08:04 ET
High
1.490
Open
1.400
Turnover
2.37M
Low
1.284
Pre Close
1.240
Volume
1.71M
Market Cap
15.80M
P/E(TTM)
Loss
52wk High
4.100
Shares
11.53M
P/E(Static)
Loss
52wk Low
0.303
Float Cap
5.14M
Bid/Ask %
18.75%
Historical High
4.240
Shs Float
3.75M
Volume Ratio
1.49
Historical Low
0.303
Dividend TTM
--
Div Yield TTM
--
P/B
2.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
45.54%
Amplitude
16.61%
Avg Price
1.385
Lot Size
1
Float Cap
5.14M
Bid/Ask %
18.75%
Historical High
4.240
Shs Float
3.75M
Volume Ratio
1.49
Historical Low
0.303
Dividend TTM
--
P/B
2.22
Dividend LFY
--
Turnover Ratio
45.54%
Amplitude
16.61%
Avg Price
1.385
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Hillstream BioPharma, Inc. is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers. It also develops the Trident Artificial Intelligence (TAI) precision medicine platform which is used to identify biomarkers in its clinical programs to target a specific patient segment. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
CEO: Mr. Randy Milby
Market: NASDAQ
Listing Date: 01/12/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist